Navitoclax (ABT-263) is a potent oral Bcl-2 inhibitor that binds to Bcl-xL, Bcl-2, and Bcl-w proteins (Ki<1 nM), demonstrating antitumor activity and inducing apoptosis.
Molecular Weight:
974.61
Purity:
95.82%
CAS Number:
[923564-51-6]
Formula:
C47H55ClF3N5O6S3
Target:
Bcl-2 Family
T2101
* VAT and and shipping costs not included. Errors and price changes excepted